Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

Cytomegalovirus Disease

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...

Yellow Fever

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...

Diseases of the Liver and Gallbladder

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...

Viruses with RNA Genomes

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Loss of erythrocyte sialic acid in sepsis disrupts inhibitory Siglec interactions, driving neutrophil hyperactivation and NET outspread.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Two-Trace Two-Dimensional (2T2D) Correlation Spectroscopy of Lymphocytes in Infectious Mononucleosis.

Applied spectroscopy·2026

Same author

The changes of fecal calprotectin and lactoferrin during Clostridioides difficile infection.

Anaerobe·2026

Same author

Oral Vancomycin in the Treatment of <i>Clostridioides difficile</i> Infection: A Single-Center Observational Study in Southern Poland (2016-2022), Involving 528,887 Hospitalized Patients.

Antibiotics (Basel, Switzerland)·2026

Same author

Fatty acids profile in plasma of patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM).

Folia medica Cracoviensia·2025

Same author

The influence of chronic hepatitis B virus infection on fatty acid composition in erythrocyte membranes and plasma, and its effect on lipoxin A4 and resolvin D1 levels.

Folia medica Cracoviensia·2025

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

A Protocol for Analyzing Hepatitis C Virus Replication

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Viral hepatitis C.

Jacek Czepiel¹, Grazyna Biesiada, Tomasz Mach

¹Department of Gastroenterology, Hepatology and Infectious Diseases, Jagiellonian University Medical College, Kraków, Poland. jacz@op.pl

Polskie Archiwum Medycyny Wewnetrznej

|February 11, 2009

Summary

Hepatitis C virus (HCV) infection affects millions globally, often asymptomatic initially. Treatment effectiveness for HCV varies by genotype, with higher cure rates for genotypes 2 and 3 compared to genotype 1.

Area of Science:

Hepatology
Virology
Infectious Diseases

Background:

Hepatitis C virus (HCV) infection is a significant global health concern, affecting approximately 170 million people worldwide.
The majority of acute HCV infections are asymptomatic, with a high progression rate to chronic hepatitis C.
Chronic hepatitis C can lead to severe liver conditions, including cirrhosis.

Purpose of the Study:

To summarize the epidemiology, clinical presentation, diagnosis, and treatment of Hepatitis C virus infection.
To highlight the impact of HCV genotypes on disease progression and treatment outcomes.

Main Methods:

Review of epidemiological data from the World Health Organization.
Description of diagnostic methods including ELISA for anti-HCV antibodies and RT-PCR for HCV-RNA.

More Related Videos

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Related Experiment Videos

Last Updated: Jun 25, 2026

A Protocol for Analyzing Hepatitis C Virus Replication

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Overview of current treatment regimens involving pegylated interferon alfa and ribavirin.

Main Results:

HCV infection often presents with non-specific symptoms in the acute phase, progressing to chronic disease in 70-80% of cases.
Diagnostic tools include antibody detection (ELISA) and viral RNA quantification (RT-PCR).
Treatment success rates vary by genotype: 78% for genotypes 2 and 3, and 55% for genotype 1.

Conclusions:

Hepatitis C requires timely diagnosis and genotype-specific treatment for effective management.
Understanding HCV epidemiology and treatment outcomes is crucial for public health strategies.
Further research may improve treatment efficacy across all HCV genotypes.